Direct-acting antivirals
Showing 1 - 25 of 8,764
HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))
Not yet recruiting
- HCV
- Prophylaxis (P2W)
- Transmit and Treat (T&T)
-
New Orleans, Louisiana
- +5 more
Dec 6, 2022
Treatment of Hepatitis c by Using Direct-acting Antiviral
Not yet recruiting
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
May 9, 2022
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Recruiting
- Hepatitis C
- Direct Acting Antivirals
-
Atlanta, GeorgiaThe Taskforce for Global Health
May 6, 2022
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022
Possible Differences in HCC Course Depending on DAA Treatment
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Direct Acting Antivirals
-
Warsaw, Mazowieckie, PolandMedical University of Warsaw
May 11, 2022
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
DAA Uptake in Controlling HCV Epidemic and Modeling
Recruiting
- Hepatitis C
- +2 more
-
San Diego, CaliforniaOwen Clinic-University of California, San Diego
Sep 1, 2021
Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))
Terminated
- Hepatitis C Infection
- MBL-HCV1
- +2 more
-
Boston, Massachusetts
- +4 more
Feb 4, 2021
Kidney Failure, Hepatitis C Trial (Direct Acting Antivirals)
Withdrawn
- Kidney Failure
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
Aug 12, 2020
Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
- +2 more
-
Bilaspur, Chhattisgarh, IndiaYR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021
Chronic Hepatitis c After Treatment With Direct Action
Completed
- Hepatitis C, Chronic
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021
s of Achieving SVR in Advanced Hepatic Fibrosis Related to
Completed
- HCC in Chronic HCV Patients With Advanced Liver Fibrosis
- (no location specified)
Mar 7, 2020
HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],
Completed
- HCV Coinfection
- +2 more
- Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
- Sofosbuvir/Velpatasvir (SOF/VEL)
-
Baltimore, MarylandJohns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022
Direct Acting Antivirals for HCV Infection in Kidney Transplant
Completed
- Kidney Transplant; Complications
- Hepatitis C, Chronic
-
Istanbul, TurkeyIstanbul University
Nov 8, 2019
HCV RAS Testing in Public Health Programs
Unknown status
- Hepatitis C
- +3 more
- Direct Acting Antivirals
-
Chandigarh, India
- +1 more
Jan 22, 2020
Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)
Active, not recruiting
- Hepatocellular Carcinoma
- +3 more
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Jan 14, 2022
Safety of Direct-acting Antivirals in Patients With Hepatitis C
Completed
- Hepatitis C, Chronic
- Direct Acting Antivirals
- (no location specified)
Aug 5, 2019
Hepatitis C Trial (Zinc Supplement)
Not yet recruiting
- Hepatitis C
- Zinc Supplement
- (no location specified)
Jul 16, 2022
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)
Unknown status
- Chronic Hepatitis C
- sofosbuvir plus daclatasvir
- Sofosbuvir plus Ledipasvir
-
Cairo, Abbasseya, EgyptEl Demerdash Hospital
Dec 28, 2019
Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral
Recruiting
- Coronary Artery Disease
- +2 more
- Direct-acting oral anticoagulation
-
Rozzano, Milan, Italy
- +3 more
Mar 22, 2022
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Direct-acting Antiviral Drugs in Treatment of Hepatitis C in
Completed
- Inflammatory Bowel Diseases
- Hepatitis C Virus Infection
- Assess the effectiveness and safety of DAAs in patients with IBD.
- +2 more
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Jul 8, 2022
Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce
Active, not recruiting
- HCV
- +2 more
- Evaluate model of care for HCV-infected adults with on-going opioid misuse
-
Washington, District of Columbia
- +1 more
Feb 2, 2022